Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287867 · ClinicalTrials.gov registry record · NA
Trial for Treating Painful Degenerative Disc Disease
A NA study of Degenerative Disc Disease, sponsored by Regenexx.
- Recruiting
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 2
- Study locations
NCT05287867: Recruiting NA study of Degenerative Disc Disease, sponsored by Regenexx.
NCT05287867 is a NA study of Degenerative Disc Disease that is actively recruiting participants, run by Regenexx. The registered enrollment target is 42 participants, below the 168-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05287867, a NA study of Degenerative Disc Disease, is actively recruiting participants, sponsored by Regenexx.
- RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 2
- Study locations
Study Summary
To evaluate and compare two platelet-based treatments of the functional spinal unit spaced 4 weeks apart to sham procedures for the treatment of degenerative disc disease.
Primary Outcome
Difference in Numeric Pain Scale group differences (scale 0-10, where 0=no pain and 10=worst possible pain
Conditions Studied
Interventions
- BIOLOGICAL Platelet-rich plasma (PRP), Platelet lysate (PL), and Platelet Poor Plasma (PPP)
- OTHER Sham procedure
Study Locations (2)
Colorado
- Centeno-Schultz Clinic - Broomfield
- Centeno-Schultz Clinic - Lone Tree
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2022-05-06 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05287867 shows while recruiting
NCT05287867 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 168-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 2 interventions - of which Platelet-rich plasma (PRP), Platelet lysate (PL), and Platelet Poor Plasma (PPP) is the first listed.
NCT05287867 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05287867 about?
NCT05287867 is a clinical study titled "Trial for Treating Painful Degenerative Disc Disease". To evaluate and compare two platelet-based treatments of the functional spinal unit spaced 4 weeks apart to sham procedures for the treatment of degenerative disc disease.
What is the current status of trial NCT05287867?
This trial is currently recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2022-05-06. Estimated completion is 2026-12-31.
What conditions does trial NCT05287867 study?
This clinical trial studies the following conditions: Degenerative Disc Disease.
What interventions are being tested in trial NCT05287867?
The interventions under investigation include: Platelet-rich plasma (PRP), Platelet lysate (PL), and Platelet Poor Plasma (PPP) (BIOLOGICAL), Sham procedure (OTHER).
Who is sponsoring clinical trial NCT05287867?
This trial is sponsored by Regenexx, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05287867 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05287867's enrollment target sits among peer trials
42 32nd of 42 higher than 11 of 42 other Degenerative Disc Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Degenerative Disc Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.
RECRUITING · NA
-
MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion
RECRUITING · NA
-
ACDF Using Structural Allograft vs. Tritanium C
RECRUITING · NA
-
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI